SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-068716
Filing Date
2022-03-08
Accepted
2022-03-08 07:43:56
Documents
13
Period of Report
2022-03-04
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d316288d8k.htm   iXBRL 8-K 26062
2 EX-4.1 d316288dex41.htm EX-4.1 16642
  Complete submission text file 0001193125-22-068716.txt   172552

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA rgen-20220304.xsd EX-101.SCH 2871
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE rgen-20220304_lab.xml EX-101.LAB 18757
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rgen-20220304_pre.xml EX-101.PRE 11720
7 EXTRACTED XBRL INSTANCE DOCUMENT d316288d8k_htm.xml XML 3507
Mailing Address 41 SEYON STREET BUILDING 1, SUITE 100 WALTHAM MA 02453
Business Address 41 SEYON STREET BUILDING 1, SUITE 100 WALTHAM MA 02453 7814499560
REPLIGEN CORP (Filer) CIK: 0000730272 (see all company filings)

IRS No.: 042729386 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-14656 | Film No.: 22720346
SIC: 2836 Biological Products, (No Diagnostic Substances)